(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Terapia celular > DA - CIMA - Oncología - Terapia celular - Artículos de Revista >

A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients
Autor(es) : Perez-Calvo, J. (Javier)
Fernandez-Hidalgo, Ó. (Óscar)
Aristu, J. (Javier)
Aramendia, J.M. (J.M.)
Rifon, J. (Jose)
Prosper, F. (Felipe)
Bendandi, M. (Maurizio)
Rocha, E. (Eduardo)
Martin-Algarra, S. (Salvador)
Palabras clave : Mobilization
CD34
Glioma
BCNU
Transplantation
Cisplatin
Fecha incorporación: 2004
Editorial : Nature Publishing Group
Versión del editor: http://dx.doi.org/10.1038/sj.bmt.1704382
ISSN: 0268-3369
Cita: Perez-Calvo, J., Fernandez, O., Aristu, J. J., Aramendia, J. M., Rifon, J., Prosper, F. et al. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients. Bone Marrow Transplantation 2004; 1–4
Resumen
Extensive prior treatment with cytotoxic agents is associated with impaired mobilization of hematopoietic cells. To assess the effect of a single course of standarddose chemotherapy (CT), we compared the results of filgrastim-induced mobilization among two sequential groups of grade III–IV malignant glioma patients included in a hematopoietic transplantation program. The first group (21 patients) had never been treated with CT until 2 days after surgery, when they received a course of 100 mg/m2 BCNU (IV) and 100 mg intracarotid cisplatin for cytoreduction (not for mobilization). At 1 month after this CT, they were mobilized with 12 lg/kg filgrastim. The second group (22 patients) was mobilized with the same dose of filgrastim directly after the surgery, without having ever received any prior CT. The blood level of CD34þ cells was significantly lower in the CT-treated patients, both on the fourth day of filgrastim (15 vs 36 cells 106/l; P¼0.01) and on the fifth (25 vs 58 cells 106/l; P¼0.003), as it was the number of CD34þ cells collected per apheresis (1.3 vs 3.5 106/l; Po0.0005). The toxic effect of a single course of BCNUcisplatin CT led to significant impairment of the filgrastim-induced mobilization response. Bone Marrow Transplantation advance online
Enlace permanente: http://hdl.handle.net/10171/18565
Aparece en las colecciones: DA - Medicina - Oncología - Artículos de revista
DA - CIMA - Oncología - Inmunoterapia - Artículos de Revista
DA - CIMA - Oncología - Síndromes mieloproliferativos - Artículos de Revista
DA - CIMA - Oncología - Terapia celular - Artículos de Revista
DA - CUN - Hematología y Hemoterapia - Artículos de revista
DA - CUN - Área de Terapia Celular - Artículos de revista
DA - Medicina - Hematología - Artículos de revista

Ficheros en este registro:
Fichero:  2004_BMT_Perez Calvo_A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients.pdf
Descripción: 
Tamaño:  347,71 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.